论文部分内容阅读
目的通过近期疗效对比,探讨两种药物临床应用的选择。方法将67例复发性阿弗它溃疡(RAU)患者随机分成两组,实验组用康复新液,对照组用西地碘含片进行治疗,根据中华口腔医学会黏膜病专业委员会的“RAU疗效评价试行标准”进行疗效评价。结果在临床疗效方面,两者比较差异无统计学意义,但是在溃疡持续时间和疼痛指数方面比较差异有统计学意义。结论实验组对于RAU缩短溃疡期及症状的改善优于对照组,康复新液可考虑作为临床治疗RAU的首选药物。
Objective To compare the efficacy of the recent trials to explore the clinical choice of two drugs. Methods Sixty-seven patients with recurrent aphthous ulcer (RAU) were randomly divided into two groups. The experimental group was treated with Kangfuxinye and the control group was treated with iodine-containing tablets. According to the “RAU of the Chinese Committee of Oral Medical Mucosal Diseases” Trial evaluation of efficacy criteria "for evaluation of efficacy. Results There was no significant difference between the two groups in clinical efficacy, but there was significant difference in duration of ulcer and pain index. Conclusion The experimental group is better than the control group in shortening the ulcer stage and improving the symptoms of RAU, and Kangfuxinye can be considered as the first choice of drug for clinical treatment of RAU.